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The number of patients undergoing shock wave lithotripsy (SWL) in the UK for solitary uni-
lateral kidney stones is increasing annually. The development of postoperative complica-
tions such as haematuria and sepsis following SWL is likely to increase. Comparing a range
of biological markers with the aim of monitoring or predicting postoperative complications
following SWL has not been extensively researched. The main purpose of this pilot-study
was to test the hypothesis that SWL results in changes to haemostatic function. Subse-
quently, this pilot-study would form a sound basis to undertake future investigations involv-
ing larger cohorts.
Methods
Twelve patients undergoing SWL for solitary unilateral kidney stones were recruited. From
patients (8 male and 4 females) aged between 31–72 years (median—43 years), venous
blood samples were collected pre-operatively (baseline), at 30, 120 and 240 minutes post-
operatively. Specific haemostatic biomarkers [platelet counts, prothrombin time (PT), acti-
vated partial thromboplastin time (aPTT), fibrinogen, D-dimer, von Willebrand Factor (vWF),
sE-selectin and plasma viscosity (PV)] were measured.
Results
Platelet counts and fibrinogen concentration were significantly decreased following SWL
(p = 0.027 and p = 0.014 respectively), while D-dimer and vWF levels significantly increased
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following SWL (p = 0.019 and p = 0.001 respectively). PT, APTT, sE-selectin and PV pa-
rameters were not significantly changed following SWL (p>0.05).
Conclusions
Changes to specific biomarkers such as plasma fibrinogen and vWF suggest that these rep-
resent a more clinically relevant assessment of the extent of haemostatic involvement fol-
lowing SWL. Analysis of such markers, in the future, may potentially provide valuable data
on “normal” response after lithotripsy, and could be expanded to identify or predict those pa-
tients at risk of coagulopathy following SWL. The validation and reliability will be assessed
through the assessment of larger cohorts.
Introduction
The prevalence and incidence of kidney stones is increasing worldwide [1]. Treatment methods
for kidney stones have significantly improved with the introduction of shock wave lithotripsy
(SWL), and this relatively non-invasive form of treatment has replaced open surgical proce-
dures for the treatment of many kidney stones [2]. More recently, it has been noted that the
number of SWL treatments for solitary unilateral kidney stones have been increasing annually,
associated with a 63% rise in upper urinary tract stones being reported in the UK over a
10-year period [3].
Whilst SWL is an efficient treatment for urinary stones, numerous reports of haemostatic
associated complications such as haematuria, as well as potentially critical intraparenchymal
haemorrhage, subcapsular haematoma, and perirenal bleeding have been reported [4–5]. In ad-
dition, there is evidence to suggest that even brief exposure to shock waves may induce changes
to the renal microvasculature, thus increasing the risk of such complications [6]. Furthermore,
recent evidence also suggests that bleeding may initiate an inflammatory response that could
result in scarring with permanent loss of functional renal volume [7]. As such, understanding
the role of haemostatic parameters may be beneficial in monitoring or predicting postoperative
complications after treatments such as SWL.
Disturbances to the normal vascular integrity, due to SWL, may result in abnormal haemos-
tasis, which can lead to bleeding or thromboembolic complications. Platelets play a critical role
during primary haemostasis (platelet plug formation) and aid in the development of blood clot-
ting. Although increased platelet counts have been reported to be dominant contributors to
hypercoagulability after injury in surgical intensive care trauma patients, little evidence has
been documented with respect to changes in platelet concentrations following SWL [8]. With
regards to secondary haemostasis (coagulation), prothrombin time (PT) and activated partial
thromboplastin time (aPTT) are performance indicator tests that measure the extrinsic and in-
trinsic coagulation pathways. A recent study by Dedej et al (2013) has demonstrated alterations
in haemostasis following abdominal surgery, where PT decreased significantly from 90.38%
preoperative to 81.25% at 72 hours postoperative [9]. Fibrinogen is a large soluble and complex
glycoprotein that is converted by thrombin into fibrin during blood clot formation. Fibrin deg-
radation products are formed whenever fibrin is broken down by enzymes (for example, plas-
min). D-dimer is an end product derived from plasmin-mediated degradation of cross-linked
fibrin clots. D-dimer measurement has proved to be a sensitive marker for the evaluation of
disseminated intravascular coagulation (DIC) [10]. von Willebrand Factor (vWF) is a large
multimeric glycoprotein and performs essential functions of haemostasis in vivo, through its
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variety of bridging and binding activities. Specific functions of vWF include its ability to act as
an essential co-factor for factor VIII in the blood coagulation cascade, platelet adhesion, plate-
let aggregation and platelet plug stabilisation. vWF has been reported as being an established
marker of endothelial activation [11–13].
E-selectin (CD62) is a cell adhesion molecule expressed on endothelial cells, which is acti-
vated by cytokines and facilitates leukocyte-endothelial interactions. Soluble E-selectin (sE-
selectin) is found in the blood, probably arising from proteolytic cleavage of the surface-ex-
pressed molecule [14]. Elevated levels of E-selectin have been reported in patients with sepsis
[15]. Plasma viscosity provides a simple and reliable way of monitoring changes in plasma pro-
teins as a result of trauma, inflammation or infection. During an inflammatory process, it can
be appreciated that the high proportion of fibrinogen in the blood causes red blood cells to
stick to each other, thus increasing plasma viscosity values.
Whilst we, and others, have previously reported post-operative changes in haemostatic
markers following various surgical procedures [13, 9, 16], crucially, there is very little evidence
investigating the direct effect of SWL on haemostatic parameters. Hence, the aim of this pilot
study, was to test the hypothesis that SWL results in changes to haemostatic function, increas-
ing endothelial and haemostatic involvement postoperatively. We aimed to evaluate changes in
selective haemostatic and endothelial biomarkers, to provide a better understanding of their
postoperative course following elective SWL, for the treatment of solitary unilateral kidney
stones. This pilot-study would provide a sound platform to undertake future investigations in-
volving larger cohorts of SWL patients.
Methods
Subject Volunteers and ShockWave Lithotripsy (SWL)
Ethical approval for this pilot study was received from the Wales Research Ethics Service
(REC) 4 committee (REC4: 12/WA/0117). Twelve consecutive patients scheduled for elective
SWL for solitary unilateral kidney stones, were recruited after providing written informed con-
sent to participate in the study (n = 12). The patients (8 males and 4 females) were aged be-
tween 31 and 72 years old (median age = 43 years). Each patient served as their own control as
data was taken from baseline values (pre-treatment) through the various time points post-
treatment. Any changes in the haemostatic markers measured were due to the non-invasive
procedure as these patients did not undergo anaesthesia (general or local). Treatment was
given as per standardised protocol using Wolf P3000 device, incorporating triple focus technol-
ogy, with ultrasound and fluoroscopic imaging as appropriate.
Blood Samples
Prior to SWL, a cannula was inserted into the ante-cubital fossa, and a venous blood sample
was collected pre-operatively, which stood as a baseline measurement for that particular pa-
tient. After SWL, further blood samples were collected at 30 minutes, 120 minutes and 240
minutes post-operatively. The blood samples were collected into vacutainers containing di-po-
tassium ethylene diamine tetra-aceticacid (EDTA) and tri-sodium citrate. Subject plasma was
obtained by centrifuging whole blood samples at 450g for 15 minutes, following which all plas-
ma samples were stored (-80°C) until required for further analysis.
Measurement of platelet concentration
Complete blood counts were performed using a Sysmex XE-5000 automated cell counter and
platelets measured in units x109/L.
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Measurement of prothrombin time (PT), activated partial thromboplastin
time (aPTT) and fibrinogen
PT (seconds) was measured in citrated samples, using a Randox Monza semi-automated sys-
tem as described by the manufacturer’s instructions (Randox RXMonza Method Sheet: PTH
2752). aPTT (seconds) and fibrinogen (g/L) were measured using citrated samples on a Sysmex
CS2100 analyser.
Measurement of D-dimer, vWF and sE-selectin
D-dimer (ng/mL) was measured by a two-step enzyme immunoassay sandwich method, with a
final fluorescent detection as described by others [17]. Measurement of this parameter was per-
formed with a Mini-Vidas automated immunoassay system (Biomerieux, UK), using Enzyme-
Linked Fluorescent Assay technology. Plasma vWF concentration (IU/dL) was measured as de-
scribed previously by a sandwich-type ELISA technique, using rabbit anti-human vWF and
rabbit anti-human vWF peroxidase conjugate (Dako, UK), [11, 18–19]. Measurement of sE-
selectin (ng/mL) was performed using commercially available kits supplied by R&D Systems
Europe, and involved using ELISA assay as described by the manufacturer (R&D Systems, Cat-
alogue # SSLE00).
Measurement of plasma viscosity (PV)
Plasma viscosity (mPa/second) was measured using a Benson BV200 viscometer.
Statistical Analysis
All results were presented as mean ± standard error (SE) or median ± Iqr. Where data was nor-
mally distributed, repeated measures one-way analysis of variance (ANOVA) between samples
test was employed, adopting a 5% level of significance. Post hoc testing was conducted using
the Bonferroni test for pairwise comparisons between means. Data that did not comply with
normality were analysed using the Friedman test. Where the Friedman test resulted in statisti-
cal significance, subsequent tests were performed using the Wilcoxon test. Statistical signifi-
cance was accepted when p 0.05.
Results
Platelet Count
As displayed in Fig 1, following SWL, significant changes, compared to baseline, in platelet
concentration were observed (p = 0.027, as determined by ANOVA). Specifically, platelet val-
ues decreased from baseline (255.08 ± 19.97), during 30 minutes (243.67 ± 17.28) and 120 min-
utes postoperative (188.33 ± 18.21). At 240 minutes postoperative platelet counts increased
(229.56 ± 20.58), although remained lower to those of basal values. Upon further analysis, pair-
wise comparisons showed no significant differences between baseline vs 30, 120 and 240 min-
utes postoperative (p>0.05).
Fibrinogen
Fig 2 shows the changes in fibrinogen concentration following SWL. Following SWL, a signifi-
cant decrease in fibrinogen concentration was observed (p = 0.014, as determined by ANOVA).
Fibrinogen levels decreased from baseline (3.34 ± 0.28), during 30 and 120 minutes postoperative
(3.13 ± 0.19, 3.01 ± 0.25 respectively). Fibrinogen concentration increased at 240 minutes post-
operative (3.03 ± 0.22), although remained lower to those of basal values. Upon further analysis,
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pairwise comparisons showed significant differences between baseline (pre-operative) vs 120
minutes postoperative (p = 0.026).
VonWillebrand Factor
The results for changes in vWF are shown in Fig 3. Following SWL, a significant increase in
vWF was observed (p = 0.001, as determined by ANOVA). vWF increased from baseline
(130.02 ± 7.72), during 30 minutes (144.30 ± 8.36), 120 minutes (160.39 ± 11.46), and peaking
at 240 minutes (195.51 ± 12.74) postoperative. Upon further analysis, pairwise comparisons
showed significant differences between baseline (preoperative) vs 240 minutes postoperative
(p = 0.005).
Prothrombin time (PT) and activated partial thromboplastin time (aPTT)
Changes in PT and aPTT following SWL are described in Table 1. As can be observed, PT in-
creased from baseline (12.03 ± 0.43), at 30 minutes post-operatively (13.08 ± 0.66) and peaking
at 120 minutes (13.47 ± 0.89) postoperative. PT decreased toward basal levels at 240 minutes
Fig 1. Effect of SWL, for the treatment of kidney stones, on platelet count (n = 12). The points represent
mean ± SE, p = 0.027 as determined ANOVA.
doi:10.1371/journal.pone.0125840.g001
Fig 2. Effect of SWL, for the treatment of kidney stones, on fibrinogen concentration (n = 12). The
points represent mean ± SE, p = 0.014 as determined by the ANOVA test. *p = 0.026 baseline (preoperative)
vs 120 minutes postoperative as determined by the Bonferroni test for pairwise comparisons.
doi:10.1371/journal.pone.0125840.g002
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(13.14 ± 0.57) postoperative, although remained at a higher level to those of basal values. With
respect to the aPTT, there were no changes from baseline (24 ± 23) and 240 minutes postopera-
tive (24 ± 23). However, following SWL, no significant changes were observed in PT and aPTT
(p = 0.139 and p = 0.464 respectively).
D-dimer
Following SWL, a significant increase in D-dimer was observed, p = 0.019, as determined by
the Friedman test (Table 1). Specifically, D-dimer increased from baseline (245 ± 168), during
30 minutes (429 ± 252) and peaking at 120 minutes (1233 ± 323) postoperative. D-dimer de-
creased toward basal levels at 240 minutes (568 ± 357) postoperative, although remained at a
higher level (2 fold) to those of basal values. Upon further analysis the Wilcoxon test showed
significant differences between baseline (preoperative) vs 120 and 24 0 minutes postoperative
(p = 0.008 and p = 0.038 respectively).
sE-selectin
There was no change in sE-selectin values (Table 1) from baseline (84 ± 40) up to 30 minutes
postoperative (84 ± 46), although trends of decreasing concentrations was observed at 120 and
240 minutes postoperative (66.8 ± 41 and 66.2 ± 39 respectively). However, following SWL, no
significant changes to sE-selectin was observed (p = 0.269, as determined by the Friedman
test).
Fig 3. Effect of SWL, for the treatment of kidney stones, on vWF concentration (n = 12). The points
represent mean ± SE, p = 0.001 as determined by ANOVA. *p = 0.005 baseline (preoperative) vs 240
minutes postoperative, as determined by the Bonferroni test for pairwise comparisons.
doi:10.1371/journal.pone.0125840.g003
Table 1. Effect of SWL, for the treatment of kidney stones, on PT, aPPT, D-dimer, sE-Selectin and PV, (n = 12).
Baseline 30 minutes 120 minutes 240 minutes p value Statistical Test
PT (s) 12.03 ± 0.43 13.08 ± 0.66 13.47 ± 0.89 13.14 ± 0.57 0.139 ANOVA (± SE)
aPPT (s) 24 ± 23 24 ± 23 24 ± 23 24 ± 23 0.464 Friedman (± Iqr)
D-Dimer (ng/ml) 245 ± 168 429 ± 252 1233 ± 323* 568 ± 357* 0.019 Friedman (± Iqr)
sE-selectin (ng/ml) 84 ± 40 84 ± 46 66.8 ± 41 66.2 ± 39 0.269 Friedman (± Iqr)
PV (mPa/s) 1.66 ± 0.03 1.64 ± 0.04 1.56 ± 0.03 1.55 ± 0.04 0.129 ANOVA (± SE)
*p<0.05 (D-dimer): Baseline (preoperative) vs 120 (p = 0.008) and 240 (p = 0.038) minutes postoperative, as determined by the Wilcoxon test.
doi:10.1371/journal.pone.0125840.t001
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Plasma Viscosity
Table 1 demonstrates the changes in plasma viscosity following SWL. PV decreased from base-
line (1.66 ± 0.03 preoperative), during 30 (1.64 ± 0.04), 120 (1.56 ± 0.03) and 240 minutes post-
operative (1.55 ± 0.04). However, there were no significant changes to PV following SWL
(p = 0.129, as determined by ANOVA),
Discussion
The main aim of this pilot-study was to evaluate changes in selective haemostatic and endothe-
lial biomarkers, to provide a better understanding of their postoperative course following elec-
tive SWL, for the treatment of solitary unilateral kidney stones. As such, we have shown that
significant changes in several haemostatic biomarkers do occur following SWL.
During the present study, none of the patients developed any complications in the immedi-
ate or follow up period, clinically or radiologically. As such, this pilot study provides potentially
valuable data on “normal” response after lithotripsy. However, our study demonstrated a sig-
nificant increase in vWF from baseline up to 240 minutes (4 hours) postoperatively. This is
consistent with our previous reports of increasing vWF concentrations in the post-operative
period following other surgical procedures [13]. The inference is that SWL may result in an in-
creased liberation of vWF from the storage organelles of the vascular endothelium following
treatment, causing disruption to vascular integrity, which may lead to bleeding or thromboem-
bolic complications. Results from this study also showed decreasing platelet concentration fol-
lowing SWL, providing evidence of diminished thrombocytic activity during the postoperative
period. Our findings compliment the work by Dedej (2013) who reported similar findings of
decreased platelet values at 72 hours following abdominal surgery [9]. Clearly, if reproduced in
subsequent studies, this finding may have possible clinical implications, in potentially identify-
ing or predicting those patients at highest risk of developing haematuria or renal haematomas
following SWL. A possible explanation for the changes of platelet counts and fibrinogen ob-
served during this study might be the redistribution of them in the body due to renal trauma
caused by SWL, by which the platelet counts and fibrinogen will be increased at the kidney (the
traumatized organ) immediate after SWL, and decreased at the peripheral blood. Subsequently,
after 2 or 3 hours these parameters may regain their normal distribution. Theoretically, this
may enhance intrinsic haemostatic activity in the early post-SWL period.
Measurement of D-dimer, which is a marker of haemostatic activity, showed a significant
increase in concentration following SWL (p = 0.019). These observations were similar to those
of Umekawa et al (1993), who reported a transient acceleration in fibrin degradation products
(FDP) and D-dimer levels following SWL [20]. Interestingly, no significant changes were ob-
served in the PT and aPTT following SWL, although fibrinogen concentration decreased signif-
icantly (p = 0.014). Changes to fibrinogen levels are known to lead to either bleeding or
thromboembolic complications. A recent study by Yang et al (2013) demonstrated that lower
postoperative fibrinogen levels were associated with bleeding after cardiothoracic surgery [21].
Our finding followed a similar pattern of decreasing fibrinogen concentration up to 240 min-
utes (4 hours) following SWL, and requires further investigation to clarify the role of fibrinogen
as a potentially modifiable risk factor for perioperative bleeding, that may occur following
SWL. With regards to sE-selectin and plasma viscosity, no significant changes were observed
in these parameters.
To date, there are very few reports on the effect of SWL, for the treatment of kidney stones,
on haemostatic function, and as such, the results from this study are a welcome addition to the
urological literature. We have shown that changes to specific biomarkers, such as fibrinogen
and vWF concentrations, occur following SWL. If these results are reproduced in larger studies,
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there is a putative suggestion that these markers may provide a more clinically relevant assess-
ment of the extent of haemostatic involvement following SWL.
It is acknowledged that the main limiting factor of this pilot-study is the relatively small
number of patients recruited (n = 12), but we feel that further work can be performed to look
at these haemostatic markers, as well as inflammatory markers and their correlation with clini-
cal outcome (e.g. bleeding and infection), in a larger cohort. Although none of the patients dur-
ing this study had an untoward outcome, it would be beneficial for future investigations to
include a control other than the patients themselves. Although ethical approval would not be
granted for SWL to be performed with normal healthy individuals (i.e. those without kidney
stones); comparing patients undergoing flexible ureteroscopy, for the treatment of kidney
stones, would provide an alternative control measure, and help generate unique results to es-
tablish the extent of inflammation and changes to haemostatic parameters following both
procedures.
It would also have been interesting to have followed up the patients with regards to mea-
surement of their biological markers at review clinic’s, this could have indicated any continued
haemostatic reactions post-treatment, which may have had an impact in supporting surgeons
with their management strategies of patients during the post-operative period.
Ultimately, if changes to haemostatic markers following SWL can identify or predict those
patients at increased risk of coagulopathy, future directions of this study may offer the potential
of pharmacological intervention. For example, using anti-haemorrhagic agents as preventative
measures for post-operative bleeding, could improve patients’ recovery following SWL for the
treatment of kidney stones.
In conclusion, changes to specific biomarkers such as plasma fibrinogen and vWF suggest
that these represent a more clinically relevant assessment of the extent of haemostatic involve-
ment following SWL. Analysis of such markers, in the future, may potentially provide valuable
data on “normal” response after lithotripsy, and could be expanded to identify or predict those
patients at risk of coagulopathy following SWL. The validation and reliability will be assessed
through the assessment of larger cohorts.
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